A few of the major factors propelling market expansion during the forecast period are likely to be increased technological developments in magnetoencephalography (MEG) systems and their rising adoption, as well as the rising prevalence of neurological disorders that cause death and disability globally. Additionally, it is thought that as the population ages, the prevalence of neurodegenerative diseases will rise. These diseases typically affect persons in their medium to late years of life. The MEG scanner is one of the greatest devices for studying epilepsy, brain tumours, emotions, pain perception, and other neurological conditions. The advantage of MEG is that neuromagnetic impulses pass through the skull and scalp undisturbed. The technology has been around for a while, but recent advancements in hardware and computational power have raised interest in scanners. As a result, neurodegenerative illnesses are more prevalent, which is assisting the growth of the magnetoencephalography market. An innovative form of sensor that is now accessible for tracking neuromagnetic impulses is an optically pumped magnetometer (OPM). The laser light intensity is measured by a photodiode in the traditional optically pumped magnetometer design after it has gone through a glass cell containing gas.

The Covid 19 pandemic will result in positive growth rather than revenue loss for the global magnetoencephalography market. The COVID-19 neurological symptoms range from mild (such as headaches, dizziness, and loss of taste and smell) to severe (e.g. ischemic stroke, encephalitis). Due to thrombotic problems, inflammatory side effects, hypoxia, and blood pressure dysregulation, the underlying mechanisms may be both direct and indirect (neurotropic properties of the virus). The majority of the articles were opinion pieces, and no studies on the impacts on cognition have been done, thus more research is required. Magnetoencephalography (MEG) tools can map brain activity and gauge brain functionality by detecting the minute magnetic fields produced in the brain. There are several inherent applications for MEG in a therapeutic setting. Scanners can be used in a silent, secure environment even when a patient's partner is present inside the secured area because of the passive nature of the recordings. Leading competitors on the market are acquiring medium and small-sized businesses to expand their manufacturing capacities and broaden their product portfolios.

This study provides market data by competitive landscape, revenue analysis, market segments and detailed analysis of key market players such as: Compumedics Limited, Croton Healthcare, CTF MEG International Services LP, Field Line Inc., Ricoh Company Ltd.

 

By Application: Based on the Application, Global Magnetoencephalography Market is segmented as; Clinical (Autism, Dementia, Epilepsy, Multiple Sclerosis, Schizophrenia, Stroke, Others), Research.

 

By End User: Based on the End User, Global Magnetoencephalography Market is segmented as; Hospitals, Imaging Centres, Academic and Research Institutes.

By Region: The market was led by North America, which also contributed the largest portion of revenue. Both the presence of several market rivals in the area and the regular release of new products appear to be driving factors in the expansion of the regional market. Additionally, the quality of healthcare and patient outcomes are major concerns in the United States, and numerous projects have been established to address these issues.

This study also encompasses various drivers and restraining factors of this market for the forecast period. Various growth opportunities are also discussed in the report.